Clinical Research Strategies

Houston, Texas 77030

1 studies enrolling now · 2 studies all time

What they study most

End Stage Kidney Disease, Kidney Transplant Rejection

Studies at this site

• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD) — Recruiting now
• TruGraf® Long-term Clinical Outcomes Study — Status unconfirmed